Fractyl, hoping its GLP-1 gene therapy can take on Wegovy, plans IPO

cafead

Administrator
Staff member
  • cafead   Dec 15, 2023 at 09:52: AM
via With the gold rush in obesity meds showing no sign of abating, Fractyl Health is gearing up to go public as it gathers preclinical evidence that its GLP-1 gene therapy could take on Novo Nordisk’s Wegovy.

article source
 

<